Table 3.
Variable | BAV group (N = 330) | TAV group (N = 330) | P value |
---|---|---|---|
Atrial fibrillation | 113 (34) | 121 (37) | .52 |
Complete heart block or pacemaker | 7 (2.1) | 12 (3.6) | .24 |
Myocardial infarction | 1 (0.3) | 0 (0) | 1.0 |
Stroke | 3 (0.9) | 5 (1.5) | .72 |
Reoperation for bleeding | 7 (2.1) | 11 (3.3) | .34 |
Creatinine, mg/dL | 1.1 (0.9, 1.2) | 1.1 (0.9, 1.3) | .24 |
Time to extubation, h | 8.1 (4.4, 17) | 8.9 (4.6, 17) | .72 |
Blood transfusion | 108 (33) | 98 (30) | .41 |
RBC transfusion, units | 2.0 (2.0, 4.0) | 2.0 (2.0, 4.0) | .99 |
New-onset renal failure | 2 (0.6) | 5 (1.5) | .45 |
Hospital stay, d | 6 (5, 9) | 7 (5, 11) | .001 |
In-hospital mortality | 6 (1.8) | 3 (1.0) | .51 |
30-d mortality | 6 (1.8) | 4 (1.2) | .52 |
P value indicates the difference in the incidence rate between the BAV and TAV groups. Significant P values are in bold type. BAV, Bicuspid aortic valve; TAV, tricuspid aortic valve; RBC, red blood cell.